Prevalence and risk factors of obesity in children with Diamond-Blackfan anemia
YI Mei-Hui, WAN Yang, CHENG Si-Qi, GONG Xiao-Wen, YIN Zi-Xi, LI Jun, GAO Yang-Yang, WU Chao, ZONG Su-Yu, CHANG Li-Xian, CHEN Yu-Mei, ZHENG Rong-Xiu, ZHU Xiao-Fan
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China
Abstract:Objective To investigate the distribution of body mass index (BMI) and risk factors for obesity in children with Diamond-Blackfan Anemia (DBA). Methods The children with DBA who attended National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, from January 2003 to December 2020 were enrolled as subjects. The related clinical data and treatment regimens were recorded. The height and weight data measured within 1 week before or after follow-up time points were collected to calculate BMI. The risk factors for obesity were determined by multivariate regression analysis in children with DBA. Results A total of 129 children with DBA were enrolled, among whom there were 80 boys (62.0%) and 49 girls (38.0%), with a median age of 49 months (range 3-189 months). The prevalence rate of obesity was 14.7% (19/129). The multivariate logistic regression analysis showed that the absence of ribosomal protein gene mutation was closely associated with obesity in children with DBA (adjusted OR=3.63, 95%CI: 1.16-11.38, adjusted P=0.027). In children with glucocorticoid-dependent DBA, obesity was not associated with age of initiation of glucocorticoid therapy, duration of glucocorticoid therapy, and maintenance dose of glucocorticoids (P>0.05). Conclusions There is a high prevalence rate of obesity in children with DBA, and the absence of ribosomal protein gene mutation is closely associated with obesity in children with DBA.
YI Mei-Hui,WAN Yang,CHENG Si-Qi et al. Prevalence and risk factors of obesity in children with Diamond-Blackfan anemia[J]. CJCP, 2022, 24(10): 1143-1148.
Da Costa L, O'Donohue MF, van Dooijeweert B, et al. Molecular approaches to diagnose Diamond-Blackfan anemia: the EuroDBA experience[J]. Eur J Med Genet, 2018, 61(11): 664-673. PMID: 29081386. DOI: 10.1016/j.ejmg.2017.10.017.
Vlachos A, Blanc L, Lipton JM. Diamond Blackfan anemia: a model for the translational approach to understanding human disease[J]. Expert Rev Hematol, 2014, 7(3): 359-372. PMID: 24665981. DOI: 10.1586/17474086.2014.897923.
Vlachos A, Osorio DS, Atsidaftos E, et al. Increased prevalence of congenital heart disease in children with Diamond Blackfan anemia suggests unrecognized Diamond Blackfan anemia as a cause of congenital heart disease in the general population: a report of the Diamond Blackfan Anemia Registry[J]. Circ Genom Precis Med, 2018, 11(5): e002044. PMID: 29748317. PMCID: PMC5951415. DOI: 10.1161/CIRCGENETICS.117.002044.
Gazda HT, Sheen MR, Vlachos A, et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients[J]. Am J Hum Genet, 2008, 83(6): 769-780. PMID: 19061985. PMCID: PMC2668101. DOI: 10.1016/j.ajhg.2008.11.004.
Pospisilova D, Cmejlova J, Ludikova B, et al. The Czech National Diamond-Blackfan Anemia Registry: clinical data and ribosomal protein mutations update[J]. Blood Cells Mol Dis, 2012, 48(4): 209-218. PMID: 22381658. DOI: 10.1016/j.bcmd.2012.02.002.
Chen S, Warszawski J, Bader-Meunier B, et al. Diamond-Blackfan anemia and growth status: the French registry[J]. J Pediatr, 2005, 147(5): 669-673. PMID: 16291361. DOI: 10.1016/j.jpeds.2005.06.007.
Sichieri R, Dos Santos Barbosa F, Moura EC. Relationship between short stature and obesity in Brazil: a multilevel analysis[J]. Br J Nutr, 2010, 103(10): 1534-1538. PMID: 20070916. DOI: 10.1017/S0007114509993448.
Paetow U, Bader P, Chemaitilly W. A systematic approach to the endocrine care of survivors of pediatric hematopoietic stem cell transplantation[J]. Cancer Metastasis Rev, 2020, 39(1): 69-78. PMID: 31980968. DOI: 10.1007/s10555-020-09864-z.
Murillo-Sanjuán L, González-Vicent M, Argilés Aparicio B, et al. Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children[J]. Bone Marrow Transplant, 2021, 56(5): 1213-1216. PMID: 33303901. DOI: 10.1038/s41409-020-01172-y.